查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2019780

家庭靜脈輸液治療市場規模、佔有率、成長及全球產業分析：按類型、應用和地區分類的洞察，2026-2034 年預測

Home Infusion Therapy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 128 Pages | 商品交期: 請詢問到貨日

價格

家庭靜脈輸液治療市場的成長要素

受消費者對經濟高效、以患者為中心的醫療保健解決方案需求不斷成長的推動，全球家庭輸液治療市場正經歷顯著成長。預計到2025年，該市場規模將達到424.4億美元，2026年將成長至456.7億美元，到2034年將達到1,289.1億美元，預測期內複合年成長率高達13.85%。北美地區憑藉先進的醫療保健基礎設施和有利的報銷政策，引領市場發展，預計到2025年將佔41.20%的市場佔有率。

居家輸液治療是指在患者家中進行生物製藥及靜脈注射藥物等治療。這種方法可以減少患者就醫次數，降低治療費用，並提高患者的舒適度。人們對居家醫療的日益重視，以及輸液治療設備的科技進步，正在加速居家輸液治療在全球的普及。

市場趨勢

塑造市場格局的關鍵趨勢之一是向居家醫療的轉變。由於便利性、縮短住院時間以及降低院內感染風險等原因，患者和醫療服務提供者越來越傾向於居家治療。遠端醫療、穿戴式監測設備和攜帶式輸液系統的整合進一步提高了居家輸液治療的安全性和有效性。

此外，新冠肺炎疫情加劇了這一轉變，加重了醫院的負擔，並促使患者尋求更安全的替代方案。自從疫情爆發以來，這一趨勢仍在繼續，分散式醫療模式在醫療保健系統中變得越來越重要。

市場成長要素

成長要素之一是癌症、糖尿病和免疫系統疾病等慢性病盛行率的上升。這些疾病通常需要長期輸液治療，因此居家治療方案更具吸引力。此外，老年人口的成長也進一步促進了市場成長，老年人更傾向於居家治療。

另一個重要因素是人們對經濟實惠的醫療保健需求日益成長。居家靜脈輸液治療可顯著降低住院費用及相關支出。研究表明，居家靜脈輸液治療比住院治療便宜得多，這促使患者和醫療服務提供者更廣泛地採用這種治療方式。

此外，人們對醫院感染的擔憂日益加劇，促使人們開始轉向居家治療方案，特別是對於免疫系統較弱的患者而言。

市場限制因素

儘管市場成長強勁，但仍面臨諸多挑戰。發展中地區缺乏報銷機制仍是一大障礙。高昂的自付醫療費用和有限的保險覆蓋範圍限制了患者獲得居家輸液服務的機會。

此外，新興市場缺乏熟練的醫療保健專業人員和基礎設施不發達，也會阻礙家庭靜脈輸液療法的廣泛應用。

市場區隔分析

從產品類型來看，市場區隔將市場分為藥品、醫療設備和服務三大類。預計到2026年，藥品領域將佔市場主導地位，市場佔有率達到77.54%，這主要得益於注射藥物核准的增加以及生物製藥產品線的強勁成長。

根據適應症，市場可細分為抗感染疾病療法、化療、經腸營養和其他領域。由於抗感染疾病應用廣泛且成本效益高，預計到2026年，該領域將以25.52%的市場佔有率佔主導地位。同時，由於癌症發生率不斷上升，化療領域預計將經歷最快的成長。

區域趨勢

北美仍然是一個關鍵地區，預計到 2025 年市場規模將達到 174.9 億美元，到 2026 年將擴大到 186.9 億美元。該地區受益於強大的居家醫療提供者網路和支持性的報銷制度。

預計到 2025 年，歐洲的市場規模將達到 136.9 億美元，由於各國政府加強推廣居家醫療，預計市場將保持穩定成長。

預計到 2025 年，亞太地區的市場規模將達到 80.7 億美元，成長速度最快，這主要得益於中國和印度等國家醫療保健意識的提高、慢性病負擔的加重以及醫療保健基礎設施的擴張。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家和地區主要慢性病盛行率
  • 新產品發布：按主要企業分類
  • 併購、收購和合作等主要產業趨勢
  • 各國/地區的法規和還款狀況
  • 新冠疫情對市場的影響

第5章：2021-2034年全球家庭靜脈輸液治療市場分析、洞察與預測

  • 市場分析、洞察與預測：按產品分類。
    • 裝置
    • 製藥
    • 服務
  • 市場分析、洞察與預測：按指標
    • 感染疾病物
    • 化療
    • 水療法
    • 經腸營養
    • 全靜脈營養
    • 免疫球蛋白療法
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第6章：北美家庭靜脈輸液治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲家庭靜脈輸液治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區家庭輸液治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 其他亞太國家

第9章：全球其他地區家庭輸液治療市場分析、洞察與預測（2021-2034年）

第10章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Option Care Health Inc.Overview
    • Optum, Inc.
    • CareCentrix, Inc.
    • Lincare Holdings Inc.
    • BriovaRx Infusion Services
    • Promptcare
    • Baxter
    • B. Braun Melsungen AG
    • Infusystem
    • Moog Inc.
Product Code: FBI102989

Growth Factors of home infusion therapy Market

The global home infusion therapy market is witnessing significant expansion, driven by the rising demand for cost-effective and patient-centric healthcare solutions. The market was valued at USD 42.44 billion in 2025 and is projected to grow to USD 45.67 billion in 2026, reaching USD 128.91 billion by 2034, exhibiting a strong CAGR of 13.85% during the forecast period. North America dominated the market with a 41.20% share in 2025, supported by advanced healthcare infrastructure and favorable reimbursement policies.

Home infusion therapy refers to the administration of medications such as biologics and intravenous drugs in a patient's home setting. This approach reduces hospital visits, lowers treatment costs, and enhances patient comfort. Increasing awareness of home-based healthcare, along with technological advancements in infusion devices, is accelerating global adoption.

Market Trends

A major trend shaping the market is the shift toward home-based medical care. Patients and healthcare providers are increasingly preferring home treatment due to convenience, reduced hospital stays, and lower risk of hospital-acquired infections. The integration of telehealth, wearable monitoring devices, and portable infusion systems has further improved the safety and efficiency of home infusion therapies.

Additionally, the COVID-19 pandemic accelerated this transition, as hospitals were overburdened and patients sought safer alternatives. The trend continues post-pandemic, with healthcare systems emphasizing decentralized care models.

Market Growth Drivers

One of the primary growth drivers is the rising prevalence of chronic diseases such as cancer, diabetes, and immune disorders. These conditions often require long-term infusion therapies, making home-based solutions highly attractive. The increasing geriatric population, which prefers receiving treatment at home, further supports market growth.

Another key factor is the growing demand for cost-effective healthcare. Home infusion therapy significantly reduces hospitalization expenses and associated costs. Studies indicate that home-based infusion treatments can be substantially cheaper than hospital-based care, encouraging wider adoption among patients and healthcare providers.

Moreover, increasing concerns about hospital-acquired infections are pushing patients toward home treatment options, especially those with compromised immune systems.

Market Restraints

Despite strong growth, the market faces certain challenges. The lack of reimbursement policies in developing regions remains a major barrier. High out-of-pocket healthcare expenses and limited insurance coverage restrict patient access to home infusion services.

Additionally, shortage of skilled healthcare professionals and limited infrastructure in emerging markets can hinder the widespread adoption of home infusion therapy.

Market Segmentation Analysis

By product type, the market is segmented into drugs, devices, and services. The drugs segment dominated the market with a 77.54% share in 2026, driven by increasing approvals of injectable therapies and a strong pipeline of biologics.

By indication, the market includes anti-infective therapies, chemotherapy, enteral nutrition, and others. The anti-infective segment led the market with a 25.52% share in 2026, owing to its widespread use and cost-effectiveness. Meanwhile, the chemotherapy segment is expected to witness the fastest growth due to rising cancer prevalence.

Regional Insights

North America remains the leading region, with a market size of USD 17.49 billion in 2025, growing to USD 18.69 billion in 2026. The region benefits from a strong network of home healthcare providers and supportive reimbursement frameworks.

Europe accounted for USD 13.69 billion in 2025 and is expected to grow steadily due to increasing government initiatives promoting home healthcare.

Asia Pacific, valued at USD 8.07 billion in 2025, is projected to witness the fastest growth due to rising healthcare awareness, increasing chronic disease burden, and expanding healthcare infrastructure in countries such as China and India.

Competitive Landscape

The market is moderately consolidated, with key players such as Option Care Health, Optum, CVS Health, and Baxter International focusing on expanding service offerings and technological innovations. Strategic collaborations, acquisitions, and partnerships are commonly adopted to strengthen market presence and improve patient access to home infusion services.

Conclusion

The home infusion therapy market is poised for robust growth, driven by the increasing need for cost-effective, patient-friendly healthcare solutions. With market value expected to rise from USD 42.44 billion in 2025 to USD 128.91 billion by 2034, the industry reflects strong long-term potential. While challenges such as reimbursement limitations and infrastructure gaps persist, advancements in technology, supportive government initiatives, and growing patient preference for home-based care will continue to drive market expansion.

Segmentation By Product

  • Devices
  • Drugs
  • Services

By Indication

  • Anti-Infective
  • Chemotherapy
  • Hydration Therapy
  • Enteral Nutrition
  • Total Parenteral Nutrition
  • Immunoglobulin Therapy
  • Others

By Geography

  • North America (By Product, By Indication, and By Country)
    • U.S. (By Indication)
    • Canada (By Indication)
  • Europe (By Product, By Indication, and By Country/Sub-region)
    • U.K. (By Indication)
    • Germany (By Indication)
    • France (By Indication)
    • Italy (By Indication)
    • Spain (By Indication)
    • Scandinavia (By Indication)
    • Rest of Europe (By Indication)
  • Asia Pacific (By Product, By Indication, and By Country/Sub-region)
    • Japan (By Indication)
    • India (By Indication)
    • China (By Indication)
    • Australia (By Indication)
    • Rest of Asia Pacific (By Indication)
  • Rest of the World (By Product and By Indication)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Chronic Diseases, Key Countries/Regions, 2025
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Development such as Mergers, Acquisition, and Partnerships
  • 4.4. Regulatory & Reimbursements Scenario, By Countries/Regions
  • 4.5. Covid-19 Impact on the Market

5. Global Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Devices
    • 5.1.2. Drugs
    • 5.1.3. Services
  • 5.2. Market Analysis, Insights and Forecast - By Indication
    • 5.2.1. Anti-Infective
    • 5.2.2. Chemotherapy
    • 5.2.3. Hydration Therapy
    • 5.2.4. Enternal Nutrition
    • 5.2.5. Total Parenteral Nutrition
    • 5.2.6. Immunoglobulin Therapy
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Rest of the World

6. North America Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Devices
    • 6.1.2. Drugs
    • 6.1.3. Services
  • 6.2. Market Analysis, Insights and Forecast - By Indication
    • 6.2.1. Anti-Infective
    • 6.2.2. Chemotherapy
    • 6.2.3. Hydration Therapy
    • 6.2.4. Enternal Nutrition
    • 6.2.5. Total Parenteral Nutrition
    • 6.2.6. Immunoglobulin Therapy
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
      • 6.3.1.1. By Indication
    • 6.3.2. Canada
      • 6.3.2.1. By Indication

7. Europe Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Devices
    • 7.1.2. Drugs
    • 7.1.3. Services
  • 7.2. Market Analysis, Insights and Forecast - By Indication
    • 7.2.1. Anti-Infective
    • 7.2.2. Chemotherapy
    • 7.2.3. Hydration Therapy
    • 7.2.4. Enternal Nutrition
    • 7.2.5. Total Parenteral Nutrition
    • 7.2.6. Immunoglobulin Therapy
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
      • 7.3.1.1. By Indication
    • 7.3.2. Germany
      • 7.3.2.1. By Indication
    • 7.3.3. France
      • 7.3.3.1. By Indication
    • 7.3.4. Spain
      • 7.3.4.1. By Indication
    • 7.3.5. Italy
      • 7.3.5.1. By Indication
    • 7.3.6. Scandinavia
      • 7.3.6.1. By Indication
    • 7.3.7. Rest of Europe
      • 7.3.7.1. By Indication

8. Asia Pacific Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Devices
    • 8.1.2. Drugs
    • 8.1.3. Services
  • 8.2. Market Analysis, Insights and Forecast - By Indication
    • 8.2.1. Anti-Infective
    • 8.2.2. Chemotherapy
    • 8.2.3. Hydration Therapy
    • 8.2.4. Enternal Nutrition
    • 8.2.5. Total Parenteral Nutrition
    • 8.2.6. Immunoglobulin Therapy
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
      • 8.3.1.1. By Indication
    • 8.3.2. China
      • 8.3.2.1. By Indication
    • 8.3.3. India
      • 8.3.3.1. By Indication
    • 8.3.4. Australia
      • 8.3.4.1. By Indication
    • 8.3.5. Rest of Asia Pacific
      • 8.3.5.1. By Indication

9. Rest of the World Home Infusion Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Devices
    • 9.1.2. Drugs
    • 9.1.3. Services
  • 9.2. Market Analysis, Insights and Forecast - By Indication
    • 9.2.1. Anti-Infective
    • 9.2.2. Chemotherapy
    • 9.2.3. Hydration Therapy
    • 9.2.4. Enternal Nutrition
    • 9.2.5. Total Parenteral Nutrition
    • 9.2.6. Immunoglobulin Therapy
    • 9.2.7. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Option Care Health Inc.Overview
      • 10.2.1.1. Products & Services
      • 10.2.1.2. SWOT Analysis
      • 10.2.1.3. Recent Developments
      • 10.2.1.4. Strategies
      • 10.2.1.5. Financials (Based on Availability)
    • 10.2.2. Optum, Inc.
      • 10.2.2.1. Products & Services
      • 10.2.2.2. SWOT Analysis
      • 10.2.2.3. Recent Developments
      • 10.2.2.4. Strategies
      • 10.2.2.5. Financials (Based on Availability)
    • 10.2.3. CareCentrix, Inc.
      • 10.2.3.1. Products & Services
      • 10.2.3.2. SWOT Analysis
      • 10.2.3.3. Recent Developments
      • 10.2.3.4. Strategies
      • 10.2.3.5. Financials (Based on Availability)
    • 10.2.4. Lincare Holdings Inc.
      • 10.2.4.1. Products & Services
      • 10.2.4.2. SWOT Analysis
      • 10.2.4.3. Recent Developments
      • 10.2.4.4. Strategies
      • 10.2.4.5. Financials (Based on Availability)
    • 10.2.5. BriovaRx Infusion Services
      • 10.2.5.1. Products & Services
      • 10.2.5.2. SWOT Analysis
      • 10.2.5.3. Recent Developments
      • 10.2.5.4. Strategies
      • 10.2.5.5. Financials (Based on Availability)
    • 10.2.6. Promptcare
      • 10.2.6.1. Products & Services
      • 10.2.6.2. SWOT Analysis
      • 10.2.6.3. Recent Developments
      • 10.2.6.4. Strategies
      • 10.2.6.5. Financials (Based on Availability)
    • 10.2.7. Baxter
      • 10.2.7.1. Products & Services
      • 10.2.7.2. SWOT Analysis
      • 10.2.7.3. Recent Developments
      • 10.2.7.4. Strategies
      • 10.2.7.5. Financials (Based on Availability)
    • 10.2.8. B. Braun Melsungen AG
      • 10.2.8.1. Products & Services
      • 10.2.8.2. SWOT Analysis
      • 10.2.8.3. Recent Developments
      • 10.2.8.4. Strategies
      • 10.2.8.5. Financials (Based on Availability)
    • 10.2.9. Infusystem
      • 10.2.9.1. Products & Services
      • 10.2.9.2. SWOT Analysis
      • 10.2.9.3. Recent Developments
      • 10.2.9.4. Strategies
      • 10.2.9.5. Financials (Based on Availability)
    • 10.2.10. Moog Inc.
      • 10.2.10.1. Products & Services
      • 10.2.10.2. SWOT Analysis
      • 10.2.10.3. Recent Developments
      • 10.2.10.4. Strategies
      • 10.2.10.5. Financials (Based on Availability)

List of Tables

  • Table 1: Global Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034
  • Table 3: Global Home Infusion Therapy Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 5: North America Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034
  • Table 6: North America Home Infusion Therapy Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 8: Europe Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034
  • Table 9: Europe Home Infusion Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 11: Asia Pacific Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034
  • Table 12: Asia Pacific Home Infusion Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Rest of the World Home Infusion Therapy Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Rest of the World Home Infusion Therapy Market Revenue (USD billion) Forecast, by Indication, 2021-2034

List of Figures

  • Figure 1: Global Home Infusion Therapy Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Home Infusion Therapy Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Home Infusion Therapy Market Value Share (%), by Indication, 2025 & 2034
  • Figure 4: Global Home Infusion Therapy Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Home Infusion Therapy Market Value (USD billion), by Product, 2025 & 2034
  • Figure 6: North America Home Infusion Therapy Market Value Share (%), by Product, 2025
  • Figure 7: North America Home Infusion Therapy Market Value (USD billion), by Indication, 2025 & 2034
  • Figure 8: North America Home Infusion Therapy Market Value Share (%), by Indication, 2025
  • Figure 9: North America Home Infusion Therapy Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Home Infusion Therapy Market Value Share (%), By Country, 2025
  • Figure 11: Europe Home Infusion Therapy Market Value (USD billion), by Product, 2025 & 2034
  • Figure 12: Europe Home Infusion Therapy Market Value Share (%), by Product, 2025
  • Figure 13: Europe Home Infusion Therapy Market Value (USD billion), by Indication, 2025 & 2034
  • Figure 14: Europe Home Infusion Therapy Market Value Share (%), by Indication, 2025
  • Figure 15: Europe Home Infusion Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Home Infusion Therapy Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Home Infusion Therapy Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: Asia Pacific Home Infusion Therapy Market Value Share (%), by Product, 2025
  • Figure 19: Asia Pacific Home Infusion Therapy Market Value (USD billion), by Indication, 2025 & 2034
  • Figure 20: Asia Pacific Home Infusion Therapy Market Value Share (%), by Indication, 2025
  • Figure 21: Asia Pacific Home Infusion Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Home Infusion Therapy Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Rest of the World Home Infusion Therapy Market Value (USD billion), by Product, 2025 & 2034
  • Figure 24: Rest of the World Home Infusion Therapy Market Value Share (%), by Product, 2025
  • Figure 25: Rest of the World Home Infusion Therapy Market Value (USD billion), by Indication, 2025 & 2034
  • Figure 26: Rest of the World Home Infusion Therapy Market Value Share (%), by Indication, 2025
  • Figure 27: Global Home Infusion Therapy Market Share (%), By Company, 2025